Aytu BioPharma Inc. (AYTU)
NASDAQ: AYTU
· Real-Time Price · USD
1.90
-0.07 (-3.55%)
At close: Oct 03, 2025, 3:59 PM
1.94
2.11%
Pre-market: Oct 06, 2025, 05:31 AM EDT
Aytu BioPharma Income Statement
Financials in USD. Fiscal
year is
July - June.
| Fiscal Year | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 |
Revenue | 66.38M | 69.22M | 64.8M | 71.51M | 72.75M | 85.51M | 94.22M | 97.56M | 107.4M | 104.11M | 105.58M | 102.43M | 96.67M | 92.7M | 81.99M | 74.01M | 65.63M | 57.01M | 51.68M | 39.71M |
Cost of Revenue | 20.55M | 21.74M | 22.39M | 21.1M | 23.83M | 29.93M | 33.62M | 38.46M | 40.77M | 41.2M | 42.73M | 44.57M | 44.39M | 43.96M | 46.13M | 41.3M | 35.68M | 28.07M | 16.39M | 11M |
Gross Profit | 45.83M | 47.48M | 46.37M | 50.19M | 51.24M | 57.9M | 58.95M | 61.64M | 66.63M | 62.91M | 62.85M | 57.86M | 52.28M | 48.74M | 35.85M | 32.7M | 29.95M | 28.94M | 35.3M | 28.72M |
Operating Income | -7.83M | -3.85M | -8.74M | -3.9M | -4.47M | -653K | -7.48M | -14.82M | -14.84M | -12.3M | 31.09M | 23.99M | -2.18M | -28.96M | -88.73M | -83.01M | -58.87M | -41.43M | -20.56M | -19.95M |
Interest Income | n/a | n/a | n/a | n/a | n/a | 2K | 4K | 4K | 4K | 2K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | -13.74M | 1.78M | -4.68M | -4.46M | -14.08M | -12.61M | -17.17M | -24.47M | -19.23M | -34.48M | -80.35M | -85.21M | -110.28M | -111.32M | -83.71M | -81.68M | -58.03M | -42.44M | -22.31M | -13M |
Net Income | -13.56M | 1.64M | -5.25M | -6.25M | -15.85M | -13.69M | -18M | -24.47M | -17.05M | -30.68M | -76.77M | -81.63M | -108.78M | -111.69M | -83.86M | -81.84M | -58.3M | -42.45M | -22.32M | -13M |
Selling & General & Admin | 38.28M | 40.9M | 43.58M | 43.88M | 47.48M | 50.48M | 58.47M | 67.03M | 70.08M | 73.38M | 70.76M | 69.79M | 69.88M | 73.22M | 68.46M | 62.13M | 55.87M | 48.77M | 45.67M | 40.9M |
Research & Development | 1.33M | 2.15M | 2.61M | 2.61M | 2.79M | 2.21M | 2.45M | 3.63M | 4.09M | 7.33M | 10.2M | 13.41M | 14.44M | 15.51M | 12.17M | 7.54M | 5.62M | 2.36M | 2.05M | 1.83M |
Other Expenses | 9.17M | 8.29M | 8.91M | 7.59M | 4.81M | 133K | -216K | 67K | 2.34M | 4.45M | 4.31M | 3.13M | 1.89M | 546K | -940.42K | -1.34M | -2.05M | -2.98M | -3.09M | -3.16M |
Operating Expenses | 48.78M | 51.34M | 55.11M | 54.09M | 55.08M | 55.27M | 63.15M | 73.18M | 78.96M | 85.15M | 85.26M | 87.37M | 88.39M | 93.19M | 90.16M | 81.29M | 73.84M | 63.82M | 55.66M | 48.47M |
Interest Expense | 3.7M | 7.76M | 8.12M | 8.31M | 8.6M | 3.81M | 2.55M | 3.78M | 3.86M | 24.21M | 111.39M | 109.42M | 147.45M | 141.75M | 54.57M | 54.04M | 14.65M | n/a | n/a | n/a |
Selling & Marketing Expenses | 20.91M | 22.54M | 23.89M | 23.84M | 24.27M | 25.84M | 32.09M | 37.44M | 41.45M | 43.48M | 40.42M | 39.52M | 38.71M | 40.88M | 37.73M | 33.78M | 30.31M | 29.53M | 22.93M | 17.23M |
Cost & Expenses | 65.95M | 73.08M | 72.42M | 70.11M | 71.29M | 77.59M | 94.23M | 109.1M | 119.73M | 126.36M | 127.99M | 131.94M | 132.77M | 137.15M | 136.29M | 122.59M | 109.53M | 91.89M | 72.05M | 59.47M |
Income Tax Expense | 681K | 939K | 1.34M | 2.45M | 2.04M | 1.35M | -530K | -1.36M | -2K | 20.35M | 108.89M | 108.89M | 107.42M | 87.33M | 12.02M | 19.55M | 20.4M | 20.14M | 8.27M | -9.21M |
Shares Outstanding (Basic) | 6.79M | 6.13M | 6.13M | 7.37M | 5.54M | 5.53M | 5.52M | 5.48M | 4.06M | 3.73M | 3.11M | 2.52M | 1.8M | 1.48M | 1.32M | 60K | 1.18M | 900K | 660K | 610K |
Shares Outstanding (Diluted) | 6.79M | 8.2M | 8.49M | 9.1M | 5.54M | 5.53M | 5.52M | 5.48M | 4.06M | 3.73M | 3.11M | 2.52M | 1.8M | 1.48M | 1.32M | 60K | 1.18M | 900K | 660K | 610K |
EPS (Basic) | -2.05 | 0.04 | -1.13 | -1.19 | -2.87 | -2.63 | -4.04 | -6.15 | -4.95 | -13.31 | -47.28 | -53.87 | -488.79 | -496.04 | -488.34 | -494 | -65.8 | -55.2 | -57.2 | -45.2 |
EPS (Diluted) | -2.81 | -0.72 | -1.45 | -1.23 | -2.87 | -2.63 | -4.04 | -6.15 | -4.95 | -13.31 | -47.28 | -53.87 | -488.79 | -496.04 | -488.34 | -494 | -65.8 | -55.2 | -57.2 | -45.2 |
EBITDA | 5.13M | 6.77M | 1.76M | 3.42M | 225K | 5.56M | -2.56M | -9.01M | -9.09M | -15.32M | -15.11M | -21.74M | -27.96M | -36.98M | -43.15M | -36.93M | -32.88M | -23.56M | -13.37M | -14.65M |
EBIT | -10.04M | 747K | -4.48M | -3.28M | -7.27M | -1.81M | -10.59M | -17.45M | -17.59M | -22.24M | -22.41M | -29.51M | -36.1M | -40.17M | -45.73M | -38.7M | -34.01M | -29.28M | -18.74M | -19.45M |
Depreciation & Amortization | 5.38M | 6.03M | 6.24M | 6.7M | 7.5M | 7.37M | 8.83M | 8.94M | 9.04M | 9.47M | 9.13M | 9.9M | 10.25M | 10.83M | 9.83M | 9.03M | 8.38M | 8.02M | 7.99M | 7.41M |